Treatment of secondary CNS lymphoma using CD19-targeted chimeric antigen receptor (CAR) T cells

被引：0
|
作者：
Kathryn Kline
Tim Luetkens
Rima Koka
Michael E. Kallen
Wengen Chen
Haroon Ahmad
Destiny Omili
Thierry Iraguha
Etse Gebru
Xiaoxuan Fan
Alexis Miller
Nishanthini Dishanthan
Jillian M. Baker
Kenneth A. Dietze
Kim G. Hankey
Jean A. Yared
Nancy M. Hardy
Aaron P. Rapoport
Saurabh Dahiya
Djordje Atanackovic
机构：
[1] University of Maryland Greenebaum Comprehensive Cancer Center,Cancer Immunotherapy, Fannie Angelos Cellular Therapeutics GMP Laboratory
[2] University of Maryland School of Medicine,Department of Medicine
[3] University of Maryland,Department of Microbiology and Immunology
[4] University of Maryland School of Medicine,Department of Pathology
[5] University of Maryland School of Medicine,Diagnostic Radiology and Nuclear Medicine
[6] University of Maryland School of Medicine,Department of Neurology
[7] University of Maryland Greenebaum Comprehensive Cancer Center,Transplant and Cellular Therapy Program
[8] Stanford University,undefined
来源：
Cancer Immunology, Immunotherapy | / 73卷
关键词：
B cell lymphoma; CNS lymphoma; CAR-T cells; Neurotoxicity; T cells; Cytokines;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Treatment of secondary CNS lymphoma using CD19-targeted chimeric antigen receptor (CAR) T cells
    Kline, Kathryn
    Luetkens, Tim
    Koka, Rima
    Kallen, Michael E.
    Chen, Wengen
    Ahmad, Haroon
    Omili, Destiny
    Iraguha, Thierry
    Gebru, Etse
    Fan, Xiaoxuan
    Miller, Alexis
    Dishanthan, Nishanthini
    Baker, Jillian M.
    Dietze, Kenneth A.
    Hankey, Kim G.
    Yared, Jean A.
    Hardy, Nancy M.
    Rapoport, Aaron P.
    Dahiya, Saurabh
    Atanackovic, Djordje
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2024, 73 (03)
  • [2] CD19-targeted chimeric antigen receptor (CAR) T cells in CNS relapsed acute lymphoblastic leukemia (ALL).
    Newman, Haley
    Leahy, Allison Emily Barz
    Li, Yimei
    Liu, Hongyan
    Myers, Regina M.
    DiNofia, Amanda M.
    Dolan, Joseph Gregory
    Callahan, Colleen
    Devine, Kaitlin J.
    Wray, Lisa
    June, Carl H.
    Grupp, Stephan A.
    Rheingold, Susan R.
    Maude, Shannon L.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [3] Generation of CD19-Targeted Chimeric Antigen Receptor T Cells
    Kiani, Jafar
    Naderi, Mahmood
    Torabi-Rahvar, Monireh
    Ranjbar, Azam
    Aghayan, Hamid-Reza
    Janzamin, Ehsan
    Ahmadbeigi, Naser
    ARCHIVES OF IRANIAN MEDICINE, 2019, 22 (01) : 7 - 10
  • [4] Subsequent Malignancies After CD19-Targeted Chimeric Antigen Receptor T Cells in Patients With Lymphoma
    Lorenc, Rachel
    Shouval, Roni
    Flynn, Jessica R.
    Devlin, Sean M.
    Saldia, Amethyst
    De Abia, Alejandro Luna
    De Lapuerta, Magdalena Corona
    Tomas, Ana Alarcon
    Cassanello, Giulio
    Leslie, Lori A.
    Rejeski, Kai
    Lin, Richard J.
    Scordo, Michael
    Shah, Gunjan L.
    Palomba, M. Lia
    Salles, Gilles
    Park, Jae
    Giralt, Sergio A.
    Perales, Miguel-Angel
    Ip, Andrew
    Dahi, Parastoo B.
    TRANSPLANTATION AND CELLULAR THERAPY, 2024, 30 (10): : 990 - 1000
  • [5] Autologous CD19-Targeted Chimeric Antigen Receptor (CAR)T-Cells as the Future of Systemic Lupus Erythematosus Treatment
    Kambayana, Gede
    Rini, Sandra Surya
    CURRENT RHEUMATOLOGY REVIEWS, 2023, 19 (03) : 260 - 269
  • [6] Late Events after Treatment with CD19-Targeted Chimeric Antigen Receptor Modified T Cells
    Cordeiro, Ana
    Bezerra, Evandro D.
    Hirayama, Alexandre V.
    Hill, Joshua A.
    Wu, Qian V.
    Voutsinas, Jenna
    Sorror, Mohamed L.
    Turtle, Cameron J.
    Maloney, David G.
    Bar, Merav
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2020, 26 (01) : 26 - 33
  • [7] Efficacy of humanized CD19-targeted chimeric antigen receptor (CAR)-modified T cells in children with relapsed ALL
    Maude, Shannon L.
    Barrett, David Maxwell
    Rheingold, Susan R.
    Aplenc, Richard
    Teachey, David T.
    Callahan, Colleen
    Shaw, Pamela A.
    Brogdon, Jennifer
    Young, Regina
    Scholler, John
    Marcucci, Katherine
    Kulikovskaya, Irina
    Nazimuddin, Farzana
    Zheng, Zhaohui
    Levine, Bruce
    Porter, David L.
    Lacey, Simon F.
    Melenhorst, Jan Joseph
    June, Carl H.
    Grupp, Stephan A.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [8] Efficacy of Retreatment with Humanized CD19-Targeted Chimeric Antigen Receptor (CAR)-Modified T Cells in Children with Relapsed ALL
    Maude, S.
    Barrett, D.
    Rheingold, S.
    Aplenc, R.
    Teachey, D.
    Callahan, C.
    Shaw, P.
    Brogdon, J.
    Young, R.
    Scholler, J.
    Marcucci, K.
    Levine, B.
    Porter, D.
    Lacey, S.
    Melenhorst, J.
    June, C.
    Grupp, S.
    PEDIATRIC BLOOD & CANCER, 2016, 63 : S37 - S37
  • [9] Associations of gut microbiome profiles with efficacy and toxicity in CD19-targeted chimeric antigen receptor (CAR) T cell treatment
    Schubert, M. -L
    Blumenberg, V.
    Zamir, E.
    Schmidt, S.
    Rohrbach, R.
    Waldhoff, P.
    Bozic, D.
    von Bergwelt, M.
    Mueller-Tidow, C.
    Dreger, P.
    Poeck, H.
    Schmitt, M.
    Subklewe, M.
    Stein-Thoeringer, C.
    ONCOLOGY RESEARCH AND TREATMENT, 2021, 44 : 43 - 43
  • [10] Humanized CD19-targeted chimeric antigen receptor T (CAR-T) cells for relapsed/refractory pediatric acute lymphoblastic leukemia
    Wang, Shiyuan
    Wang, Xue
    Ye, Chunying
    Cheng, Hai
    Shi, Ming
    Chen, Wei
    Qi, Kunming
    Wang, Gang
    Wu, Qingyun
    Zeng, Lingyu
    Li, Zhenyu
    Jing, Guangjun
    Zheng, Junnian
    Xu, Kailin
    Cao, Jiang
    AMERICAN JOURNAL OF HEMATOLOGY, 2021, 96 (05) : E162 - E165
12345